Blog

Dive into Facet Life Sciences’ blog for expert articles and insights on regulatory trends, scientific developments, and industry news.

FDA Type D Meetings: A New Option for Targeted, Time-Sensitive Regulatory Guidance

Effective communication with FDA through various FDA meetings is essential [...]

Navigating the FDA’s Draft Guidance on Developing Cellular and Gene Therapy (CGT) Products

By Dr. Jason Mercer, Ph. D., RAC, Strategic Regulatory Innovator [...]

Go to Top